The NPM1 mutant defines AML irrespective of blast count

被引:10
|
作者
Falini, Brunangelo [1 ,2 ]
Martelli, Maria Paola [1 ,2 ]
Brunetti, Lorenzo [3 ,4 ]
Gjertsen, Bjorn T. [5 ]
Andresen, Vibeke [5 ]
机构
[1] Univ Perugia, Inst Hematol, Ctr Hemato Oncol Res CREO, Perugia, Italy
[2] Univ Bergen, Ctr Canc Biomarkers CCBIO, Dept Clin Sci, Bergen, Norway
[3] Univ Politecn Marche, Dept Clin & Mol Sci, Ancona, Italy
[4] Azienda Ospedaliero Univ Marche, Inst Hematol, Ancona, Italy
[5] Santa Maria Misericordia Hosp, Perugia, Italy
关键词
NUCLEOPHOSMIN; LEUKEMIA;
D O I
10.1002/ajh.26946
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E187 / E189
页数:3
相关论文
共 50 条
  • [1] NPM1 mutated AML irrespective of blast count share similar immunophenotypic features
    Tariq, Munim
    Francis, Sebastian
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 172 - 172
  • [2] NPM1 mutated AML irrespective of blast count share similar immunophenotypic features
    Tariq, Munim
    Francis, Sebastian
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 201 : 172 - 172
  • [3] Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
    Christopher P. Mill
    Warren Fiskus
    Kaberi Das
    John A. Davis
    Christine E. Birdwell
    Tapan M. Kadia
    Courtney D. DiNardo
    Naval Daver
    Koichi Takahashi
    Koji Sasaki
    Gerard M. McGeehan
    Xinjia Ruan
    Xiaoping Su
    Sanam Loghavi
    Hagop Kantarjian
    Kapil N. Bhalla
    Leukemia, 2023, 37 : 1336 - 1348
  • [4] MUTANT NPM1 MARGINALLY IMPACTS TRANSLATION IN NPM1-MUTATED AML
    Brunetti, L.
    Pianigiani, G.
    Gundry, M.
    Goodell, M.
    Falini, B.
    HAEMATOLOGICA, 2024, 109 : 80 - 80
  • [5] NPM1 Mutation Detected: Does Blast Count Matter?
    Nikhil, M. Kumar
    Shrinidhi, Nathany
    Anusha, Swaminathan
    Chitresh, Yadav
    Aastha, Gupta
    Akriti, Kothari
    Paritosh, Garg
    Neha, Panda Rastogi
    Vikas, Dua
    Arun, Danewa
    Rahul, Bhargava
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2024,
  • [6] Causal linkage of presence of mutant NPM1 to efficacy of novel therapeutic agents against AML cells with mutant NPM1
    Mill, Christopher P.
    Fiskus, Warren
    Das, Kaberi
    Davis, John A.
    Birdwell, Christine E.
    Kadia, Tapan M.
    DiNardo, Courtney D.
    Daver, Naval
    Takahashi, Koichi
    Sasaki, Koji
    McGeehan, Gerard M.
    Ruan, Xinjia
    Su, Xiaoping
    Loghavi, Sanam
    Kantarjian, Hagop
    Bhalla, Kapil N.
    LEUKEMIA, 2023, 37 (06) : 1336 - 1348
  • [7] FLOW CYTOMETRIC STANDARDIZATION OF MUTANT NPM1 AND ITS UTILITY IN RAPID DETECTION OF NPM1 MUTATED AML AND MRD ASSESSMENT
    Tawde, Vaidehi
    Dalvi, Maithili
    Talele, Vedika
    Dhende, Priyanka
    Ghogale, Sitaram
    Deshpande, Nilesh
    Girase, Karishma
    Patil, Jagruti
    Chugh, Sanjoli
    Gujral, Sumeet
    Patkar, Nikhil
    Chatterjee, Gaurav
    Rajpal, Sweta
    Subramanian, P. G.
    Tembhare, Prashant
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2024, 46 : 101 - 101
  • [8] Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation
    Yi, Sha
    Wen, Lu
    He, Jing
    Wang, Youping
    Zhao, Fei
    Zhao, Jie
    Zhao, Zichu
    Cui, Guohui
    Chen, Yan
    ANNALS OF HEMATOLOGY, 2015, 94 (02) : 201 - 210
  • [9] Deguelin, a selective silencer of the NPM1 mutant, potentiates apoptosis and induces differentiation in AML cells carrying the NPM1 mutation
    Sha Yi
    Lu Wen
    Jing He
    Youping Wang
    Fei Zhao
    Jie Zhao
    Zichu Zhao
    Guohui Cui
    Yan Chen
    Annals of Hematology, 2015, 94 : 201 - 210
  • [10] Mutant NPM1 predicts outcome in younger adults with AML and normal cytogenetics
    Carol Lovegrove
    Nature Clinical Practice Oncology, 2005, 2 (11): : 544 - 544